Oryzon Genomics SA (ORYZF)
3.098
0.00 (0.00%)
USD |
OTCM |
Oct 07, 16:00
Oryzon Genomics EPS Diluted (Quarterly) : -0.0022 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0022 |
| March 31, 2026 | -0.0185 |
| December 31, 2025 | -0.0202 |
| September 30, 2025 | 0.0052 |
| June 30, 2025 | 0.0022 |
| March 31, 2025 | -0.0276 |
| December 31, 2024 | -0.023 |
| September 30, 2024 | -0.0213 |
| June 30, 2024 | 0.0018 |
| March 31, 2024 | -0.0201 |
| December 31, 2023 | -0.0317 |
| September 30, 2023 | -0.0198 |
| June 30, 2023 | 0.02 |
| March 31, 2023 | -0.0316 |
| December 31, 2022 | -0.0424 |
| September 30, 2022 | -0.0121 |
| June 30, 2022 | 0.0067 |
| Date | Value |
|---|---|
| March 31, 2022 | -0.0347 |
| September 30, 2021 | -0.0348 |
| June 30, 2021 | 0.0183 |
| March 31, 2021 | -0.0415 |
| December 31, 2020 | -0.0256 |
| September 30, 2020 | -0.0202 |
| June 30, 2020 | -0.0048 |
| March 31, 2020 | -0.0279 |
| December 31, 2019 | -0.0231 |
| September 30, 2019 | -0.025 |
| June 30, 2019 | -0.0159 |
| March 31, 2019 | -0.0356 |
| December 31, 2018 | -0.0224 |
| September 30, 2018 | -0.034 |
| June 30, 2018 | 0.0562 |
| March 31, 2018 | -0.0376 |
| March 31, 2016 | -0.028 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pharma Mar SA | -0.0652 |
| Grifols SA | 0.2631 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alkermes Plc | 0.0029 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.1678M |
| Total Expenses (Quarterly) | 0.1678M |
| Enterprise Value | 230.01M |
| Earnings Yield | -1.15% |
| Normalized Earnings Yield | -1.149 |